Wanbury Ltd. benchmarking: Perfomance to industry peers

Financial

	Wanbury	Fredun Pharma	Bharat Parenterals
Operational Metrics
Financials
5 yr Average ROE	-11.27 %	11.84 %	7.88 %
5yr average Equity Multiplier	-1.35	2.85	1.84
5yr Average Asset Turnover Ratio	1.54	1.08	0.73
5yr Avg Net Profit Margin	5.09 %	3.9 %	5.85 %
Price to Book	14.0	5.06	2.54
P/E	19.31	40.32	0.0
5yr Avg Cash Conversion Cycle	-103.0 Days	175.29 Days	107.3 Days
Inventory Days	21.96 Days	146.68 Days	52.36 Days
Days Receivable	61.39 Days	142.46 Days	167.45 Days
Days Payable	194.51 Days	112.95 Days	103.87 Days
5yr Average Interest Coverage Ratio	2.13	2.62	14.58
5yr Avg ROCE	-37.9 %	22.71 %	9.5 %
5yr Avg Operating Profit Margin	7.72 %	9.7 %	9.16 %
5 yr average Debt to Equity	0.2	0.93	0.36
5yr CAGR Net Profit	n/a	25.5 %	n/a
5yr Average Return on Assets	7.92 %	4.18 %	5.04 %
Shareholdings
Promoter Holding	43.09 %	48.93 %	67.19 %
Share Pledged by Promoters	62.18 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	3.24 %	-2.11 %	-6.65 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Wanbury	Fredun Pharma	Bharat Parenterals
Product Wise Break-Up	Product Wise Break-Up API`s & Formulation 100.0 0 Pharmaceuticals 0	Product Wise Break-Up Pharmaceuticals 0 Pharmaceutical 100.0 API`s & Formulation 0	Product Wise Break-Up Pharmaceutical 100.0 0 API`s & Formulation 0
Segment Break-Up	Segment Break-Up Pharmaceuticals 100.0	-	-
Location Wise Break-Up	Location Wise Break-Up India 30.27 Rest of the World 0 Others 69.73	Location Wise Break-Up Rest of the World 16.86 India 83.13 Others 0.01	Location Wise Break-Up Rest of the World 76.17 India 23.83